Literature DB >> 21739007

Prevalence of broncopulmonary and otorhinolaryngologic symptoms in children under investigation for gastroesophageal reflux disease: retrospective analysis.

Victor José Barbosa Santos1, Giovana Tuccille Comes, Tatiana Maria Gonçalves, Mary de Assis Carvalho, Silke Anna Thereza Weber.   

Abstract

UNLABELLED: Gastroesophageal reflux disease (GERD) is a common ailment in children, adding up to the evidence that gastroesophageal reflux is an important cofactor in upper airway disorders, especially in the pediatric population. It is very common for it to impact the upper and lower airways. Our goal was to assess the presence of otorhinolaryngological symptoms in children aged between one and twelve years in whom gastroesophageal reflux is suspected.
MATERIALS AND METHODS: We assessed data from the charts of patients up to 12 years of age submitted to 24 hour pH measuring of one of two channels, placed at 2 and 5 cm from the LEE in order to confirm the diagnosis of Gastroesophageal Reflux Disease.
RESULTS: We studied 143 charts from children who underwent 24 hour pH measuring to investigate GERD; however, only 65 were included. The most prevalent symptoms in the children were bronchopulmonary, found in 89.2%, of sinonasal symptoms (72.3%), otologic (46.1%) and repetition UAW infections (44.6%). When we compared the presence of each group of symptoms of the results from the pH measuring, no significant differences were found between the symptoms and the pH measuring results.
CONCLUSION: GERD can manifest in different ways and otorhinolaryngological symptoms are frequent in children.

Entities:  

Mesh:

Year:  2011        PMID: 21739007      PMCID: PMC9443766          DOI: 10.1590/s1808-86942011000300010

Source DB:  PubMed          Journal:  Braz J Otorhinolaryngol        ISSN: 1808-8686


  21 in total

Review 1.  Gastro-oesophageal reflux disease.

Authors:  Paul Moayyedi; Nicholas J Talley
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

2.  Mechanisms of gastroesophageal reflux in healthy premature infants.

Authors:  T I Omari; C Barnett; A Snel; W Goldsworthy; R Haslam; G Davidson; C Kirubakaran; M Bakewell; R Fraser; J Dent
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

Review 3.  Laryngeal manifestations and pediatric laryngopharyngeal reflux.

Authors:  Petros D Karkos; Samuel C Leong; Maria T Apostolidou; Theocharis Apostolidis
Journal:  Am J Otolaryngol       Date:  2006 May-Jun       Impact factor: 1.808

4.  Acid and non-acid gastro-esophageal refluxes in children with chronic pulmonary diseases.

Authors:  Claude Thilmany; Julia Beck-Ripp; Matthias Griese
Journal:  Respir Med       Date:  2006-10-16       Impact factor: 3.415

5.  Frequency of pharyngeal reflux in children with adenoid hyperplasia.

Authors:  Bahar Keles; Kayhan Ozturk; Hamdi Arbag; Engin Gunel; Bedri Ozer
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2005-04-18       Impact factor: 1.675

6.  Contact ulcer of the larynx.

Authors:  J Cherry; S I Margulies
Journal:  Laryngoscope       Date:  1968-11       Impact factor: 3.325

Review 7.  Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management.

Authors:  JoaquimPradoP Moraes-Filho; Ivan Cecconello; Joaquim Gama-Rodrigues; LuizdePaula Castro; Maria Aparecida Henry; Ulisses G Meneghelli; Eamonn Quigley
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 8.  Gastroesophageal reflux in children.

Authors:  V M Tsou; P R Bishop
Journal:  Otolaryngol Clin North Am       Date:  1998-06       Impact factor: 3.346

9.  Optimizing the diagnosis of gastroesophageal reflux in children with otolaryngologic symptoms.

Authors:  Simon S Rabinowitz; Steven Piecuch; Rima Jibaly; Ari Goldsmith; Steven M Schwarz
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-06       Impact factor: 1.675

Review 10.  Laryngopharyngeal reflux is different from classic gastroesophageal reflux disease.

Authors:  James A Koufman
Journal:  Ear Nose Throat J       Date:  2002-09       Impact factor: 1.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.